Lhasa Limited shared knowledge shared progress
Loading...

Publications

Jump to results
Authors
Publication Type
Publication Year
Related Products
Reset
New search
Publications search results
TitlePublishedTypeProducts
A New Semi-Automated Computer-Based System for Assessing the Purge of Mutagenic ImpuritiesMirabilis
Application of AOPs for Weight-of-Evidence Assessments: Rationalising Evidence for the ICH S1B(R1) Guidance Addendumpdf fileKaptis
Are all nitrosamines concerning? A review of mutagenicity and carcinogenicity dataDerek NexusLhasa Carcinogenicity DatabaseSarah NexusVitic
Assessing confidence in predictions made by knowledge-based systemsDerek Nexus
Beyond adverse outcome pathways: making toxicity predictions from event networks, SAR models, data and knowledgeKaptis
Comparing and combining in silico outcomes and in vitro mechanism-based assays to predict genotoxicitypdf fileDerek NexusVitic
Development of a network of carcinogenicity adverse outcome pathways and its employment as an evidence framework for safety assessmentKaptis
Development of an Adverse Outcome Pathway (AOP) Network for Carcinogenicity Using Expert-Derived (Q)SAR Knowledge
Development of an Adverse Outcome Pathway Network to Support an Integrated Approach to Testing and Assessment of Carcinogenic Riskpdf fileKaptis
Development of an Adverse Outcome Pathway Network to Support an Integrated Approach to Testing and Assessment of Carcinogenic Risk - PETA Science Consortium Webinar Slidespdf fileKaptis
Development of an Adverse Outcome Pathway Network to Support an Integrated Approach to Testing and Assessment of Carcinogenic Risk - SOT 2021 Presentation Slidespdf fileKaptisDerek Nexus
Employing an adverse outcome pathway framework for weight-of-evidence assessment with application to the ICH S1B guidance addendumKaptis
It’s difficult, but important, to make negative predictionsDerek Nexus
Session 3 - Exploiting AOPs as a framework to support ICH S1 risk assessments - Recording
Session 3 - Exploiting AOPs as a framework to support ICH S1 risk assessments - Slidespdf file
The importance of expert review to clarify ambiguous situations for (Q)SAR predictions under ICH M7Derek NexusSarah Nexus
Utilising Adverse Outcome Pathways as a Framework to Organise Evidence and Support Carcinogenicity Risk Assessmentpdf fileKaptis

© 2023 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).